DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS
Ellen G. Engelhardt(The Netherlands Cancer Institute), Lotte Elshof, Lodewyk F.A. Wessels(Oncode Institute), Jelle Wesseling(Leiden University Medical Center), Proteeti Bhattacharjee(The Netherlands Cancer Institute), Alastair M. Thompson(King's College - North Carolina), Fariba Behbod(University of Kansas Medical Center), Julia Houtzager(The Netherlands Cancer Institute), Daniel Rea(University Hospitals Birmingham NHS Foundation Trust), Miranda A. Gerritsma(The Netherlands Cancer Institute), Jacco van Rheenen(The Netherlands Cancer Institute), Ellen Verschuur(Borstkankervereniging Nederland), Jos Jonkers(The Netherlands Cancer Institute), Nicholas E. Navin(The University of Texas MD Anderson Cancer Center), Elinor J. Sawyer(King's College London), P. Andrew Futreal(The University of Texas MD Anderson Cancer Center), Serena Nik‐Zainal(University of Cambridge), Ritse M. Mann(Radboud University Medical Center), Frederieke van Duijnhoven(The Netherlands Cancer Institute), Eveline M. A. Bleiker(Leiden University Medical Center), Helen Davies(German Cancer Research Center), Esther H. Lips(Leiden University Medical Center), Deborah Collyar(Advocates for Youth), Marja van Oirsouw(Borstkankervereniging Nederland), Sena Alaeikhanehshir(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Hilary Stobart, Renée Schmitz(The Netherlands Cancer Institute), Rosalie Griffioen(The Netherlands Cancer Institute), Valesca P. Retèl(The Netherlands Cancer Institute), E. Shelley Hwang(University of Bern), C. M. T. Sondermeijer(The Netherlands Cancer Institute), Marjanka K. Schmidt(University of Cambridge), Donna Pinto, Nina Bijker(Amsterdam University Medical Centers)
Cited by 1
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The cancer genome
|Nature|2009|3.5k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k